Trudy R. Baker

1.2k total citations
31 papers, 881 citations indexed

About

Trudy R. Baker is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Pathology and Forensic Medicine. According to data from OpenAlex, Trudy R. Baker has authored 31 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Reproductive Medicine, 13 papers in Obstetrics and Gynecology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Trudy R. Baker's work include Ovarian cancer diagnosis and treatment (21 papers), Endometrial and Cervical Cancer Treatments (10 papers) and Intraperitoneal and Appendiceal Malignancies (7 papers). Trudy R. Baker is often cited by papers focused on Ovarian cancer diagnosis and treatment (21 papers), Endometrial and Cervical Cancer Treatments (10 papers) and Intraperitoneal and Appendiceal Malignancies (7 papers). Trudy R. Baker collaborates with scholars based in United States. Trudy R. Baker's co-authors include M. Steven Piver, Ronald E. Hempling, Shashikant B. Lele, Marion Piedmonte, Lawrence J. Emrich, Y. Tsukada, Kunle Odunsi, M.Steven Piver, John H. Malfetano and Deborah Driscoll and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Trudy R. Baker

31 papers receiving 853 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Trudy R. Baker United States 18 640 415 316 127 126 31 881
Shashikant B. Lele United States 13 531 0.8× 322 0.8× 255 0.8× 118 0.9× 123 1.0× 29 699
J A Blessing United States 10 720 1.1× 735 1.8× 406 1.3× 125 1.0× 116 0.9× 18 1.1k
Jonathan Herod United Kingdom 7 1.0k 1.6× 576 1.4× 623 2.0× 232 1.8× 103 0.8× 8 1.2k
Harushige Yokota Japan 18 697 1.1× 484 1.2× 382 1.2× 239 1.9× 124 1.0× 34 1.2k
Malkasian Gd United States 16 495 0.8× 228 0.5× 227 0.7× 121 1.0× 50 0.4× 33 739
Griffiths Ct 6 812 1.3× 340 0.8× 583 1.8× 141 1.1× 133 1.1× 6 926
Hitoshi Hareyama Japan 20 605 0.9× 842 2.0× 303 1.0× 257 2.0× 122 1.0× 42 1.3k
Stacy Nerenstone United States 7 281 0.4× 188 0.5× 237 0.8× 122 1.0× 81 0.6× 9 589
Ricardo Sáinz de la Cuesta Spain 12 587 0.9× 358 0.9× 125 0.4× 114 0.9× 79 0.6× 23 831
John L. Lovecchio United States 16 311 0.5× 231 0.6× 163 0.5× 159 1.3× 91 0.7× 36 764

Countries citing papers authored by Trudy R. Baker

Since Specialization
Citations

This map shows the geographic impact of Trudy R. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trudy R. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trudy R. Baker more than expected).

Fields of papers citing papers by Trudy R. Baker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trudy R. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trudy R. Baker. The network helps show where Trudy R. Baker may publish in the future.

Co-authorship network of co-authors of Trudy R. Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Trudy R. Baker. A scholar is included among the top collaborators of Trudy R. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trudy R. Baker. Trudy R. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piver, M. Steven, et al.. (2010). Familial ovarian cancer: A report of 658 families from the gilda radner familial ovarian cancer registry 1981-1991. Cancer. 71(S2). 582–588. 6 indexed citations
2.
Shamshirsaz, Alireza A., Matthew Withiam‐Leitch, Kunle Odunsi, et al.. (2007). Young patients with endometrial carcinoma selected for conservative treatment: A need for vigilance for synchronous ovarian carcinomas, case report and literature review. Gynecologic Oncology. 104(3). 757–760. 37 indexed citations
3.
Odunsi, Kunle, et al.. (2004). Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up. International Journal of Gynecological Cancer. 14(4). 659–664. 19 indexed citations
4.
Ghamande, Shekhar, et al.. (2003). Weekly paclitaxel in patients with recurrent or persistent advanced ovarian cancer. International Journal of Gynecological Cancer. 13(2). 142–147. 17 indexed citations
5.
Eltabbakh, Gamal H., M.Steven Piver, Ronald E. Hempling, et al.. (1998). Correlation between Extreme Drug Resistance Assay and Response to Primary Paclitaxel and Cisplatin in Patients with Epithelial Ovarian Cancer. Gynecologic Oncology. 70(3). 392–397. 32 indexed citations
6.
Hempling, Ronald E., M. Steven Piver, & Trudy R. Baker. (1995). Impact on Progression-Free Survival of Adjuvant Cyclophosphamide, Vincristine, Doxorubicin (Adriamycin), and Dacarbazine (CYVADIC) Chemotherapy for Stage I Uterine Sarcoma. American Journal of Clinical Oncology. 18(4). 282–286. 25 indexed citations
7.
Fine, Bruce A., et al.. (1995). Severe radiation morbidity in carcinoma of the cervix: impact of pretherapy surgical staging and previous surgery. International Journal of Radiation Oncology*Biology*Physics. 31(4). 717–723. 61 indexed citations
8.
Cornelison, Terri L., Trudy R. Baker, Steven Piver, & Deborah L. Driscoll. (1995). Cisplatin, Adriamycin, Etoposide, Megestrol Acetate versus Melphalan, 5-Fluorouracil, Medroxyprogesterone Acetate in the Treatment of Endometrial Carcinoma. Gynecologic Oncology. 59(2). 243–248. 19 indexed citations
9.
Piver, M. Steven, Fernando O. Recio, Trudy R. Baker, & Deborah Driscoll. (1994). Evaluation of survival after second-line intraperitoneal cisplatin-based chemotherapy for advanced ovarian cancer. Cancer. 73(6). 1693–1698. 22 indexed citations
10.
Baker, Trudy R. & M. Steven Piver. (1994). Etiology, biology, and epidemiology of ovarian cancer. Seminars in Surgical Oncology. 10(4). 242–248. 34 indexed citations
11.
Fine, Bruce A., Trudy R. Baker, Ronald E. Hempling, & Marilyn Intengan. (1994). Pregnancy Coexisting with Serous Papillary Adenocarcinoma Involving both Uterus and Ovary. Gynecologic Oncology. 53(3). 369–372. 4 indexed citations
12.
Piver, M. Steven, Trudy R. Baker, Suraj P. Bakshi, S. S. H. Gilani, & Ronald E. Hempling. (1994). Immunoscintigraphy Using 111InCyt103 Prior to Second Look Laparotomy in Ovarian Cancer. American Journal of Clinical Oncology. 17(4). 331–334. 4 indexed citations
13.
Piver, M.Steven, et al.. (1993). A phase II study of weekly cisplatin followed by cisplatin and ifosfamide in advanced or recurrent cervical carcinoma. Cancer. 71(7). 2245–2249. 14 indexed citations
14.
Piver, M.Steven, Nachimuthu Natarajan, Trudy R. Baker, et al.. (1993). Predictive value of serum CA125 following optimal cytoreductive surgery during weekly cisplatin induction therapy for advanced ovarian cancer. Journal of Surgical Oncology. 54(1). 38–44. 4 indexed citations
15.
Baker, Trudy R., et al.. (1991). Prospective Trial of Cisplatin, Adriamycin, and Dacarbazine in Metastatic Mixed Mesodermal Sarcomas of the Uterus and Ovary. American Journal of Clinical Oncology. 14(3). 246–250. 29 indexed citations
16.
Piver, M. Steven, James Fanning, & Trudy R. Baker. (1991). Phase II Trial of Cisplatin, Adriamycin, and Etoposide for Metastatic Endometrial Adenocarcinoma. American Journal of Clinical Oncology. 14(3). 200–207. 9 indexed citations
17.
Piver, M. Steven, John H. Malfetano, Trudy R. Baker, Shashikant B. Lele, & David L. Marchetti. (1989). Adjuvant cisplatin-based chemotherapy for stage I ovarian adenocarcinoma: A preliminary report. Gynecologic Oncology. 35(1). 69–72. 18 indexed citations
18.
Piver, M. Steven, et al.. (1988). The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma.. Journal of Clinical Oncology. 6(6). 983–989. 129 indexed citations
19.
Baker, Trudy R., M.Steven Piver, Shashikant B. Lele, & Yoshiaki Tsukada. (1988). Stage I uterine adenosarcoma: A report of six cases. Journal of Surgical Oncology. 37(2). 128–132. 11 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shashikant B. Lele Breakdown of academic impact, for papers by J A Blessing Breakdown of academic impact, for papers by Jonathan Herod Breakdown of academic impact, for papers by Harushige Yokota Breakdown of academic impact, for papers by Malkasian Gd Breakdown of academic impact, for papers by Griffiths Ct Breakdown of academic impact, for papers by Hitoshi Hareyama Breakdown of academic impact, for papers by Stacy Nerenstone Breakdown of academic impact, for papers by Ricardo Sáinz de la Cuesta Breakdown of academic impact, for papers by John L. Lovecchio
Rankless by CCL
2026